跳到主要內容

7827
市場
上市
產業
生技醫療業
收盤(2026/10/19)
156.50 −7.50(−4.57%)
市值
220.5 億元
股價淨值比
16.53 倍

以 FBDB™ 平台研發腫瘤免疫生物新藥

2026 年 9 月營收0元

年增
−100.00%
月增
–
累計年增
−91.14%
看月營收

備註:增減變動差異原因: 係本年為臨床藥品銷貨收入,去年同期則為授權相關履約義務已經達成而認列相關授權收入

資料來源:臺灣證券交易所、公開資訊觀測站;依政府資料開放授權條款提供。 市值(收盤價乘以發行股數)為 Livermore 依官方資料計算。

近 60 個交易日合計

三大法人在這段期間的買賣超合計,與外資持股比率的變化。

外資近 60 日(張)
+2,664
投信近 60 日(張)
0
自營商近 60 日(張)
−10
三大法人近 60 日(張)
+2,654
外資持股比率
25.73%
60 日來 +2.21 個百分點

資料來源:臺灣證券交易所;依政府資料開放授權條款提供。 期間合計與持股比率的變化為 Livermore 依官方資料計算。

三大法人買賣超

每天的買賣超,外資不含外資自營商,自營商分自行買賣與避險。單位是張(1 張 = 1,000 股),游標停在數字上可以看到股數。

三大法人買賣超
日期收盤漲跌幅外資(張)外資自營商(張)投信(張)自營商自行買賣(張)自營商避險(張)自營商(張)三大法人(張)
2026/10/19156.50−4.57%−5600−1+2+1−55
2026/10/16164.00−1.20%+5900000+59
2026/10/15166.00−1.48%+2600000+26
2026/10/14168.50+3.06%+56000−2−2+54
2026/10/13163.50−2.10%+28000+2+2+30
2026/10/12167.00−1.18%−47000+2+2−45
2026/10/8169.00+2.11%+18800−1−4−5+183
2026/10/7165.50−0.60%−11800+2+2+4−114
2026/10/6166.50−0.60%+138000+2+2+140
2026/10/5167.50+0.30%+2500000+25
2026/10/2167.00+1.21%+1800−20−2+16
2026/10/1165.000.00%+3300000+33
2026/9/30165.00+0.92%+43000−2−2+41
2026/9/29163.50+0.62%−5300000−52
2026/9/24162.50−0.31%+1300+20+2+15
2026/9/23163.000.00%+300000+3
2026/9/22163.00+0.62%+177000+1+1+178
2026/9/21162.000.00%+11400+2+1+3+117
2026/9/18162.00+8.00%+16100+1−2−1+160
2026/9/17150.00+1.01%+59000−2−2+57
2026/9/16148.50−0.67%−2400−1+10−24
2026/9/15149.50−1.64%−2900000−29
2026/9/14152.00−0.33%−26000−1−1−27
2026/9/11152.50−0.33%−50000+1+1−49
2026/9/10153.00+0.99%+200+10+1+3
2026/9/9151.50+0.33%+35000+1+1+35
2026/9/8151.00−1.95%+15000+2+2+17
2026/9/7154.00+1.99%+6000000+60
2026/9/4151.00−0.33%+6400−2−2−4+60
2026/9/3151.50−0.33%+14000−1−1+13
2026/9/2152.00−1.30%−13000+2+2−11
2026/9/1154.00−0.32%−2500+1+5+6−19
2026/8/31154.50−3.13%+1000+1+3+4+14
2026/8/28159.50−1.54%−5100000−51
2026/8/27162.00−1.22%−5500000−54
2026/8/26164.00+3.14%+27000+10+1+271
2026/8/25159.000.00%+1600+30+3+19
2026/8/24159.00−1.24%+200−30−3−1
2026/8/21161.00+0.94%+28000+1+1+29
2026/8/20159.50+3.91%+21800+1−5−4+214
2026/8/19153.50−1.60%+31000+2+2+33
2026/8/18156.00−0.64%+49000−1−1+48
2026/8/17157.00−2.48%−2000−20−2−22
2026/8/14161.00+1.26%+2100+40+4+25
2026/8/13159.00−1.85%−6000+2+2−4
2026/8/12162.00+0.62%+7100−2+20+71
2026/8/11161.00+0.63%+6800000+68
2026/8/10160.00+2.56%+14500+2−20+146
2026/8/7156.00−0.32%+9500−3−2−5+90
2026/8/6156.50+0.32%+140000−2−2+138
2026/8/5156.00+1.63%+7000+3+1+4+74
2026/8/4153.50+1.99%−200−50−5−7
2026/8/3150.50+5.61%+5400−4−4−8+46
2026/7/31142.50+1.79%+4700−2−4−6+41
2026/7/30140.00−0.71%+11200−23−1−24+88
2026/7/29141.00+0.71%+21000+3−30+211
2026/7/28140.00−1.06%+8600+23−1+22+108
2026/7/27141.50+1.07%+126000−6−6+119
2026/7/24140.00−6.04%+7500+3+2+5+80
2026/7/23149.00−3.87%−3700−2+1−1−38

資料來源:臺灣證券交易所;依政府資料開放授權條款提供。 漲跌幅為 Livermore 依官方資料計算。

融資融券

每天的融資、融券買賣與餘額,單位是張。

這段期間沒有資料。

資料來源:臺灣證券交易所;依政府資料開放授權條款提供。 增減(與前一個交易日的餘額相比)為 Livermore 依官方資料計算。

借券賣出

每天的借券賣出、還券與餘額,單位是張(來源是股數,四捨五入到張)。

這段期間沒有資料。

資料來源:臺灣證券交易所;依政府資料開放授權條款提供。 增減(與前一個交易日的餘額相比)為 Livermore 依官方資料計算。

外資持股

外資及陸資每天的持股、持股比率與尚可投資的股數,單位是張。

外資持股
日期外資持股(張)增減外資持股比率尚可投資(張)發行股數(張)投資上限
2026/10/1936,251−5625.73%104,637140,887100.00%
2026/10/1636,307+5925.76%104,581140,887100.00%
2026/10/1536,247+2625.72%104,640140,887100.00%
2026/10/1436,221+5625.70%104,666140,887100.00%
2026/10/1336,165+2825.66%104,723140,887100.00%
2026/10/1236,137−4725.64%104,751140,887100.00%
2026/10/836,184+18825.68%104,704140,887100.00%
2026/10/735,996−11825.54%104,892140,887100.00%
2026/10/636,114+13825.63%104,774140,887100.00%
2026/10/535,976+2525.53%104,912140,887100.00%
2026/10/235,951+1825.51%104,937140,887100.00%
2026/10/135,933+3325.50%104,955140,887100.00%
2026/9/3035,900+4325.48%104,987140,887100.00%
2026/9/2935,857−5325.45%105,030140,887100.00%
2026/9/2435,910+1325.48%104,978140,887100.00%
2026/9/2335,897+325.47%104,991140,887100.00%
2026/9/2235,894+17725.47%104,994140,887100.00%
2026/9/2135,717+11425.35%105,170140,887100.00%
2026/9/1835,603+16125.27%105,284140,887100.00%
2026/9/1735,442+77225.15%105,445140,887100.00%
2026/9/1634,670−2424.83%104,935139,606100.00%
2026/9/1534,694−2924.85%104,912139,606100.00%
2026/9/1434,723−2624.87%104,882139,606100.00%
2026/9/1134,749−5024.89%104,856139,606100.00%
2026/9/1034,799+224.92%104,807139,606100.00%
2026/9/934,797+3524.92%104,809139,606100.00%
2026/9/834,762+1524.90%104,843139,606100.00%
2026/9/734,747+6024.88%104,859139,606100.00%
2026/9/434,687+6424.84%104,919139,606100.00%
2026/9/334,623+1424.80%104,983139,606100.00%
2026/9/234,609−1324.79%104,997139,606100.00%
2026/9/134,622−2524.79%104,984139,606100.00%
2026/8/3134,647+1024.81%104,959139,606100.00%
2026/8/2834,637−5124.81%104,969139,606100.00%
2026/8/2734,688−5524.84%104,918139,606100.00%
2026/8/2634,743+27024.88%104,863139,606100.00%
2026/8/2534,473+1624.69%105,133139,606100.00%
2026/8/2434,457+224.68%105,149139,606100.00%
2026/8/2134,455+2824.67%105,151139,606100.00%
2026/8/2034,427+21824.65%105,179139,606100.00%
2026/8/1934,209+3124.50%105,397139,606100.00%
2026/8/1834,178+4924.48%105,428139,606100.00%
2026/8/1734,129−2024.44%105,477139,606100.00%
2026/8/1434,149+2124.46%105,457139,606100.00%
2026/8/1334,128−624.44%105,478139,606100.00%
2026/8/1234,134+7124.45%105,472139,606100.00%
2026/8/1134,063+6824.39%105,543139,606100.00%
2026/8/1033,995+14524.35%105,611139,606100.00%
2026/8/733,849+9524.24%105,756139,606100.00%
2026/8/633,754+14024.17%105,851139,606100.00%
2026/8/533,614+7024.07%105,991139,606100.00%
2026/8/433,544−224.02%106,061139,606100.00%
2026/8/333,546+5424.02%106,059139,606100.00%
2026/7/3133,492+4723.99%106,113139,606100.00%
2026/7/3033,445+11223.95%106,160139,606100.00%
2026/7/2933,333+21023.87%106,272139,606100.00%
2026/7/2833,123+8623.72%106,483139,606100.00%
2026/7/2733,037+12623.66%106,569139,606100.00%
2026/7/2432,911+7523.57%106,694139,606100.00%
2026/7/2332,836−3723.52%106,769139,606100.00%

資料來源:臺灣證券交易所;依政府資料開放授權條款提供。 增減(與前一個交易日的餘額相比)為 Livermore 依官方資料計算。